Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Eli Lilly 22.974, Roche 17.5245.
* Roche reports semi-annually. Values are evenly split across both quarters within each half.
Eli Lilly vs Roche: Revenue Comparison
Eli Lilly (LLY) and Roche (RHHBY) are peers in GLP-1. Eli Lilly reported revenue of $23.0B as of Q2 2026, compared with $35.0B for Roche. Roche leads on revenue.
Eli Lilly's gross margin is 85.8% versus 73.7% for Roche. Eli Lilly's net margin is 30.9% versus 22.6% for Roche.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Eli Lilly, Roche.| Metric | Eli Lilly | Roche |
|---|---|---|
| Market Cap | - | - |
| Revenue | $22.97B | $35.05B |
| Cost of Revenue | $3.27B | $9.21B |
| Gross Profit | $19.71B | $25.84B |
| Operating Income | $8.98B | $10.90B |
| Net Income | $7.09B | $7.93B |
| R&D Expense | $3.82B | $8.35B |
| Earnings Per Share | $7.94 | $1.23 |
| Gross Margin | 85.8% | 73.7% |
| Operating Margin | 39.1% | 31.1% |
| Net Profit Margin | 30.9% | 22.6% |
| Free Cash Flow | $7.76B | $6.46B |
| Cumulative Free Cash Flow | $109.66B | $305.80B |
| Operating Cash Flow | $10.69B | $8.28B |
| Cash & Equivalents | $8.89B | $6.13B |